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Integrin α5β1 is essential for vascular development but it remains unclear precisely where and how it
functions. Here, we report that deletion of the gene encoding the integrin-α5 subunit (Itga5) using the
Pdgfrb-Cre transgenic mouse line, leads to oedema, haemorrhage and increased levels of embryonic
lethality. Unexpectedly, these defects were not caused by loss of α5 from Pdgfrb-Cre expressing mural
cells (pericytes and vascular smooth muscle cells), which wrap around the endothelium and stabilise
blood vessels, nor by defects in the heart or great vessels, but were due to abnormal development of the
lymphatic vasculature. Reminiscent of the pathologies seen in the human lymphatic malformation, fetal
cystic hygroma, α5 mutants display defects both in the separation of their blood and lymphatic
vasculature and in the formation of the lymphovenous valves. As a consequence, α5-deﬁcient mice
develop dilated, blood-ﬁlled lymphatic vessels and lymphatic capillaries that are ectopically covered
with smooth muscle cells. Analysis of the expression of Pdgfrb during lymphatic development suggests
that these defects probably arise from loss of α5β1 integrin in subsets of specialised Prox1þ Pdgfrbþ
venous endothelial cells that are essential for the separation of the jugular lymph sac from the cardinal
vein and formation of the lymphovenous valve leaﬂets.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The integrin family of extracellular matrix receptors are key
regulators of both blood and lymphatic vessel development
(Astrof and Hynes, 2009; Avraamides et al., 2008; Chen et al.,
2012; Hynes, 2007; Tammela and Alitalo, 2010). Multiple integrins,
including the ﬁbronectin receptors (α5β1, αvβ3, αvβ5, αvβ6,
α4β1), have been implicated to one degree or another in angio-
genesis and a number of integrin inhibitors have entered clinical
trials to test their ability to prevent tumor angiogenesis (Goodman
and Picard, 2012). Integrin α5β1 binds the Arg-Gly-Asp (RGD)
motif in ﬁbronectin and is the predominant ﬁbronectin-binding
integrin. α5β1 is poorly expressed on quiescent endothelium, but
is upregulated during developmental and tumor angiogenesis
(Kim et al., 2000; Xie et al., 2011). Genetic ablation of α5, or its
major ligand, ﬁbronectin, results in embryonic lethality at E10.5
due to severe vascular defects (Francis et al., 2002; George et al.,
1997; George et al., 1993; Yang et al., 1993). Furthermore,
inhibition of α5β1 leads to decreases in angiogenesis and tumor
growth in both chicken and mouse models (Kim et al., 2000;
Muether et al., 2007; Umeda et al., 2006).
Some studies have also implicated α5β1 integrin in develop-
ment of the lymphatic vasculature (Chen et al., 2012). The main
function of the lymphatic system is to maintain tissue ﬂuid
balance (Fol̈di and Stros̈senreuther, 2005). Blind-ended lymphatic
capillaries collect excess interstitial ﬂuid extravasated from the
blood and drain it back via collecting lymphatic vessels, lymph
nodes and ﬁnally the lymphatic duct to the venous circulation
(Tammela and Alitalo, 2010). Within collecting lymphatic vessels,
intra-luminal valves (herein referred to as lymphatic valves)
ensure unidirectional lymphatic ﬂow (Bazigou and Makinen,
2013), while at the junctions of the lymphatic ducts with the
venous circulation, lymphovenous valves allow ﬂuid to drain into
the veins and prevent blood from entering into the lymphatic
circulation. in vitro, α5β1 is required for activation of vascu-
lar endothelial growth factor receptor-3 (VEGFR-3) (Zhang et al.,
2005), which plays an essential role in lymphangiogenesis (Alitalo,
2011). Proliferation and growth of lymphatic endothelial cells
(ECs) has also been blocked by small-molecule antagonists of
α5β1 in corneal and airway inﬂammation models in vivo (Dietrich
et al., 2007; Okazaki et al., 2009).
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The role of endothelial α5β1 during development however
remains unclear due to compensation by other integrins and the
inﬂuence of strain-dependent genetic modiﬁers (van der Flier et al.,
2010). Ablation of endothelial α5β1 fails to produce the major defects
seen with global knockouts of α5 (van der Flier et al., 2010). On a
129S4 background, Tie2-Cre-mediated deletion of Itga5 leads to late
embryonic lethality apparently due to patent ductus arteriosus (van
der Flier et al., 2010). Ablation of both α5 and αv integrin subunits in
endothelial cells produced remodelling defects in the major vessels
but these were still much less severe than observed in the global α5
knockout mice. These results suggest that α5β1 integrin functions in
other cell types to contribute to the observed vascular defects in α5-
null embryos.
Much less information exists about the roles of integrins on
mural cells, which wrap around both blood and collecting lym-
phatic vessels. The physiological importance of mural cells in
blood vessel development can be seen in mice that lack platelet-
derived-growth-factor-B (PDGF-B), or its receptor, PDGF receptor-
β (PDGFRβ). PDGF-B is secreted from ECs and promotes the
proliferation and migration of PDGFRβ-positive mural cell pre-
cursors to the vessel wall (Hirschi et al., 1999). Loss of either PDGF-
B or PDGFRβ results in blood vessels that lack, or are incompletely
covered by, mural cells (Leveen et al., 1994; Soriano, 1994). As a
consequence, ECs hyperproliferate, form abnormal junctions and
give rise to dilated, leaky vessels (Hellstrom et al., 1999; Lindahl et
al., 1997).
Recently, two papers have shown that integrin-β1 is essential
for mural cell function in vivo. In both studies, mural-cell-speciﬁc
deletion of β1 led to the formation of aneurysms and defects in the
assembly of ECM proteins within the vessel wall (Abraham et al.,
2008; Turlo et al., 2012). In mice where Itgb1was deleted using the
Pdgfrb-Cre transgene, mural cells also appeared round, poorly
spread, and only loosely attached to the subendothelial basement
membrane (Abraham et al., 2008). Electron microscopic studies
have shown that dense ﬁbronectin-rich plaques form at the
pericyte-endothelial interface suggesting an important role for
ﬁbronectin-binding integrins (Courtoy and Boyles, 1983). Mural
cells express several β1 heterodimers that bind to ﬁbronectin,
including α5β1 (Davenpeck et al., 2001), which is upregulated
during differentiation of mesenchymal stem cells to pericytes
(Kale et al., 2005). Integrin α5β1 has also been shown to promote
proliferation, migration, and switching of vascular smooth muscle
cells (vSMCs) from a contractile to synthetic phenotype (Barillari
et al., 2001; Davenpeck et al., 2001; Hedin and Thyberg, 1987), and
to regulate signalling through PDGFRβ (Veevers-Lowe et al., 2011).
To date, however, no one has investigated the role of α5β1 on
either pericytes or vSMCs in vivo.
To address the function of α5β1 on mural cells in vivo, we used
a conditional gene targeting approach to disrupt expression of
Itga5 selectively in both pericytes and vSMCs. We found, again
unexpectedly, that deletion of α5β1 integrin from mural cells
failed to produce major defects in blood vessel development. We
did however observe defects in the lymphatics. Accordingly, we
report here on the development of both blood vessels and
lymphatics in mice lacking α5β1 integrin in cell types that express
Pdgfrb-Cre–these include pericytes, vSMCs and, as we report here,
a subset of endothelial cells that appear to be involved in
separations between the two vascular systems.
Materials and methods
Mouse lines
All mouse strains used were on a 129S4:C57BL/6 mixed genetic
background. Itga5 ﬂoxed mice (van der Flier et al., 2010), Itgav ﬂoxed
mice (Lacy-Hulbert et al., 2007), transgenic Pdgfrb-Cre (Foo et al.,
2006), Tie2-Cre (Kisanuki et al., 2001), mTmG (Muzumdar et al., 2007),
VE-Cadherin-CreERT2 (Benedito et al., 2009) and Pf4-Cre (Tiedt et al.,
2007) mouse lines have all been described previously. Genotyping was
performed on DNA isolated from tail snips either in-house or by
Transnetyx. For experiments involving the VE-Cadherin-CreERT2 line,
pregnant females were given intraperitoneal injections of 2 mg
Tamoxifen (dissolved in peanut oil) at E8.5, E9.5, and E10.5.
Histology and immunoﬂuorescence staining
Freshly isolated embryos were embedded in Tissue-Tek OCT and
sectioned (20 μm) on a Cryostat; or ﬁxed in 4% paraformaldehyde
(PFA) in PBS at 4 1C overnight or in zinc ﬁxative (BD) at room
temperature (RT) for 48 h, followed by embedding and sectioning
(5 μm) in parafﬁn wax. Selected parafﬁn sections were stained with
hematoxylin and eosin (H&E) using standard protocols. For immuno-
ﬂuorescence staining, deparafﬁnized tissue sections were subjected to
heat-induced epitope retrieval (25min 800W microwave) in
10 mM Tris, 1 mM EDTA, 0.05% Tween 20, pH 9.0, blocked in PBS
containing 0.5% Tween and 2% goat or donkey serum (PBS-Tb), and
incubated overnight at 4 1C with primary antibodies diluted in 1:1
PBS:PBS-Tb. After washes in PBS-T (PBS 0.1% Tween), tissues were
incubated either at RT for 2 h, or overnight at 4 1C, with ﬂuorophore-
conjugated secondary antibodies diluted in 1:1 PBS-Tb. Samples were
then washed in PBS-T, mounted onto coverslips in Fluoromount
(SouthernBiotech) and imaged using Zeiss LSM 510 or Nikon A1R
scanning laser confocal microscopes. Images were processed using
Volocity (Perkin Elmer) or Nikon elements software. Whole-mount
staining of PFA-ﬁxed embryonic back skin followed methods pre-
viously described (Foo et al., 2006).
Antibodies
Rat anti-mouse PECAM-1, MEC13.3 (BD Pharmingen), rabbit anti-
mouse PECAM-1 (Abcam), mouse anti-human α–SMA, Clone1A4-Cy3
(Sigma), rabbit anti-Desmin (Abcam), rat anti-mouse Ter-119 (BD
Pharmingen), rabbit anti-mouse LYVE-1 (Abcam), hamster-anti mouse
Podoplanin (Developmental Studies Hybridoma Bank), goat anti-
mouse Integrin-α9 (R&D systems), goat anti-human Prox1 (R&D
systems), rabbit anti-Prox1 (Angiobio), rat anti-mouse integrin-α5
(BD Pharmingen), goat anti-GFP (Abcam), rabbit anti-GFP (Cell Signal-
ling), rabbit anti-mouse PDGFRβ 28E1 (Cell Technology), rabbit anti-
αSMA (Abcam). Secondary antibodies were Alexa488, Alexa594, and
Alexa647 conjugated antibodies (Invitrogen).
Micro-CT scans
PFA (4%)-ﬁxed embryos were stained with a proprietary con-
trast agent and scanned with a high-resolution volumetric micro-
CT scanner (μCT40 ScanCo Medical, Zurich, CH) using the follow-
ing parameters: 6 μm isometric voxel resolution at 200 ms expo-
sure time, 2000 views and 5 frames per view (Numira Biosciences
(Salt Lake City, UT). The micro-CT generated DICOM ﬁles were
analyzed using OsiriX and Volocity software.
Results
Loss of integrin-α5 from PDGFRβ-positive cells results in oedema
During development of the vascular system, α5β1 is expressed
on both endothelial and mural cells within the blood vessel wall
(Fig. S1A). To study the role of α5β1 on pericytes and vSMCs,
female homozygous Itga5-ﬂoxed mice (van der Flier et al., 2010)
were crossed to male Pdgfrb-Cre-positive (Foo et al., 2006)
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heterozygous Itga5-ﬂoxed mice. Isolation of the resulting mutant
embryos, herein referred to as Itga5Pdgfrb-cre mice, revealed efﬁcient
loss of α5 protein within the vSMC layers of the aorta by
embryonic day 13.5 (E13.5) (Fig. S1B), and an increased incidence
of intrauterine death from E13.5 (Fig. S2A). By E15.5, 80% of
Itga5Pdgfrb-cre mice displayed oedema and, in 35% of mutants,
widespread accumulation of blood within the skin (Fig. 1A–C,
S2B). Itga5Pdgfrb-cre mice that survived to E17.5 (65%) however
appeared to have resolved these defects and survived to birth (Fig.
S2B). Interestingly, Itga5Pdgfrb-cre mice also developed blood-ﬁlled
jugular lymphatic sacs (Fig. 1C and E). However in the majority of
the mice, this was observed only on the left side of the embryos
suggesting a left-side predilection (Fig. S2B). To rule out cardiac
dysfunction as the cause of these defects, we completed micro-CT
scans through the thoracic region of control and Itga5Pdgfrb-cre
embryos at E15.5. However, no obvious defects in either the
development of the heart or remodelling of the outﬂow tract were
detected in the absence of α5β1 (Fig. 1F, G, Movie S1, S2).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.05.006.
Normal blood vessel development in Itga5Pdgfrb-cre mice
Previous studies have shown that defective mural cell coverage
leads to haemorrhage, oedema and embryonic lethality due to
instability of the vessel wall (Hellstrom et al., 1999; Kogata et al.,
2009). Analysis of the embryonic dermal vasculature by whole-
mount immunostaining surprisingly revealed no obvious defects
in vSMC or pericyte morphology (Fig. 2), despite efﬁcient deletion
of mural cell α5 protein (Fig. S1B). In contrast to the rounded
morphology seen in mice lacking mural cell expression of all β1
integrins (Abraham et al., 2008), Itga5-deﬁcient vSMCs formed
organised concentric rings around arteries and continuously
covered large veins (Fig. 2B and D). Loss of Itga5 did however
cause abnormal recruitment of αSMA-positive cells to lymphatic
capillaries of the skin (Fig. 2D and F), which in contrast to the
collecting lymphatic vessels, are usually devoid of smooth muscle
cells in order to allow efﬁcient absorption of interstitial ﬂuid
(Petrova et al., 2004). Desmin-positive pericytes also appeared
unaffected by the loss of integrin-α5. Pericytes in Itga5Pdgfrb-cre
mice were elongated, in close association with the capillary
endothelium (Fig. 2G, H), and in similar numbers to those seen
in control mice (Fig. S3).
Itga5Pdgfrb-cre mice display blood-ﬁlled, hyperplastic lymphatic vessels
Since the haemorrhage and oedema in Itga5Pdgfrb-cre mice could
not be attributed to obvious defects in formation of the vascular
wall and ectopic vSMC coverage was seen around lymphatic
vessels (Fig. 2D and F), samples of embryonic skin from E15.5
embryos were stained with the pan-endothelial marker PECAM-1,
the lymphatic endothelial marker LYVE-1, and the erythroid cell
control Itgα5Pdgfrb-cre
Itgα5Pdgfrb-crecontrolItgα5Pdgfrb-crecontrol
JLS JLS
*
*
*
Fig. 1. Phenotype of Itga5Pdgfrb-cre mutant mice. Freshly isolated E15.5 control (A) and Itga5Pdgfrb-cre embryos (B, enlarged in C). Itga5Pdgfrb-cre mutants display oedema (asterisk,
B), accumulation of blood within the skin (arrowhead in C), and blood-ﬁlled jugular lymph sacs (arrow, C). H&E sections showing control (D) and blood-ﬁlled jugular lymph
sac (JLS) in E15.5 Itga5Pdgfrb-cre mutants (E). Micro-CT section of E15.5 control (F) and Itga5Pdgfrb-cre hearts showing development of the tricuspid and mitral valves
(arrowheads) and the absence of ventricular septal defects (*) in mutant embryos (G). See also Movies 1 and 2 in Supplementary Material. Scale bar: 20 μm.
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Fig. 2. Normal blood vessel morphology in Itga5Pdgfrb-cre mice. (A-H) Whole-mount immunoﬂuorescence staining of control and mutant embryonic skin at E17.5. (A, B) No
obvious defects seen in vSMC (red) attachment or morphology around arteries (a) and veins (v) in Itga5Pdgfrb-cre mice. (C, D) Low magniﬁcation images showing the extent of
vSMC coverage throughout the vasculature in a control (C) and Itgα5Pdgfrb-cre embryo (D). Notice the ectopic vSMC coverage around lymphatic capillaries (white arrows) (D),
which are absent in control embryos (C). Higher magniﬁcation image of a lymphatic capillary (green) in control skin (E) and ectopic αSMA coverage around a lymphatic
capillary in an Itgα5Pdgfrb-cre embryo (F). Desmin-positive pericytes apposed to microvessels in control (G) and Itgα5Pdgfrb-cre mutants (H). Scale bars: 50 μm (A, B,), 200 μm (C,
D), 50 μm (E, F), 10 μm (G, H).
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marker Ter-119 (Fig. 3A–F). In control mice, erythrocytes were
contained within the blood vasculature (Fig. 3A, B), and blind-
ended lymphatic capillaries appeared 2–3 times the size of the
largest blood vessels. In contrast, in Itga5Pdgfrb-cre embryos, lym-
phatic vessels appeared hyperplastic, tortuous and were often
ﬁlled with blood (Fig. 3C, D). The distribution of LYVE-1 was also
different in mutant embryos. Instead of the uniform LYVE-1
expression seen in control mice, endothelial cells in lymphatic
capillaries of Itga5Pdgfrb-cre embryos had increased levels of LYVE-1
at their cell junctions (Fig. 3D). Despite these lymphatic defects,
blood vessels in Itga5Pdgfrb-cre mutants appeared indistinguishable
from those in control mice (Fig. 3E), and even in the most severely
affected mutants, no aneurysms or dilation of blood vessels were
ever observed (Fig. 3F).
Pdgfrb-cre is expressed in a population of cells within the jugular
lymph sac and lymphovenous valves
Previous results have shown that Pdgfrb is expressed on newly
formed lymphatic vessels in the corneas of mice treated with
PDGF-B (Cao et al., 2004) and in endothelial cells in vitro (Heldin
and Westermark, 1999). To address whether the defects observed
in Itga5Pdgfrb-cre mutants could be due to deletion of α5 throughout
the lymphatic endothelium we analysed the expression of Pdgfrb,
by crossing the Pdgfrb-Cre line with the mTmG reporter mouse
(Pdgfrbmtmg), in which Cre-mediated excision results in the expres-
sion of membrane-bound GFP (Muzumdar et al., 2007). As
expected, Pdgfrb is highly expressed in both pericytes and vSMCs,
but is absent from the vascular endothelium and lymphatic
capillaries within the skin (Fig. S4A–D).
GFPþ cells were however detected in a subset of LYVE-1þ
lymphatic ECs in the jugular lymph sacs (JLSs) (Fig. 4A, B), and in a
population of Prox1þ cells in the internal jugular (IJV) and subclavian
veins (SCV), adjacent to where the lymphatic sac (LS) merges with the
venous endothelium to form the two lymphovenous valves and drain
ﬂuid back into the blood circulation (Fig. 4C–E). As described by
Srinivasan and Oliver (2011), the lymphovenous valves form through
the fusion of the LSs (Fig. 4A) with the veins in a region containing a
subpopulation of Prox1þ FoxC2þ venous ECs within the IJV and SCV
(Fig. 4A). Lymphovenous valves consist of two leaﬂets, each containing
two layers of Prox1þ cells (Fig. 4A, S5A). The inner layer of cells is
derived from the LSs and expresses podoplanin (Fig. 4A, S5B), while
the outer layer is derived from the specialised Prox1þ FoxC2þ
podoplanin- cells found in the walls of the veins (Fig. 4A, S5B)
(Srinivasan and Oliver, 2011). Interestingly, analysis of the Pdgfrbmtmg
mice revealed that Pdgfrb-Cre is also expressed within these specia-
lised venous ECs in the outer layer of the lymphovenous valve leaﬂets
or their progenitors (Fig. 4F). Furthermore, a subpopulation of
PDGFRβ-positive cells was still detectable in the outer layer of the
valves at E13.5 (Fig. S5C). These cells did not appear to be pericytes or
vSMCs, since they lacked the mural cell markers desmin and αSMA
(Fig. S5B). In addition to Pdgfrb, the lymphovenous valves also
expressed high levels of integrin-α5 (Fig. 4G), along with the lympha-
tic valve marker (and ﬁbronectin receptor) integrin-α9 (Fig. 4H)
(Bazigou et al., 2009). This is in contrast to the valves within the
collecting lymphatic vessels, where only low levels of α5 have been
reported (Bazigou et al., 2009).
Separation of the jugular lymph sacs from the cardinal vein is delayed
in Itga5Pdgfrb-cre mice
Development of the lymphatic system in mice starts at E9.75
when Prox1 turns on in a subpopulation of LYVE-1þ ECs in the
lateral parts of the anterior cardinal vein (CV) (Srinivasan et al.,
2007; Wigle and Oliver, 1999). Prox1þ lymphatic progenitor cells
then bud, and migrate from the CV in response to VEGF-C from the
mesoderm to form the JLSs and the superﬁcial lymphatic vessels,
respectively (Francois et al., 2012; Hagerling et al., 2013; Yang et
al., 2012). During the budding of the JLSs, nascent lymph sacs
become transiently ﬁlled with blood until complete separation
from the CV occurs at E12.5, and the lymphovenous valves form
and allow the lymph sacs to drain into the venous circulation
(Francois et al., 2012; van der Putte, 1975). Failure to separate the
JLSs from the CV leads to prolonged bleeding into the lymph sacs,
tortuous blood-ﬁlled cutaneous lymphatic vessels and eventually
embryonic death (Abtahian et al., 2003; D'Amico et al., 2009;
Uhrin et al., 2010).
Since Pdgfrb-Cre is expressed within Prox1þ ECs in the venous
endothelium and in a subset of cells within the JLSs (Fig. 4), we
examined whether the defects observed in Itga5Pdgfrb-cre embryos
might also be due to a failure of the JLS to separate from the CV.
Consistent with previous reports, at E10.5 the anterior CV of Itga5Pdgfrb-
cre embryos expressed LYVE-1 (Wigle et al., 2002) and contained
equivalent numbers of Prox1þ progenitor cells when compared with
control mice (Fig. 5A, B). By E12.5, LYVE-1 expression was no longer
present in the CV, and both control and mutant embryos had clearly
visible lymph sacs (Fig. 5C, D). However, in contrast to control embryos
(Fig. 5C), JLSs in E12.5 Itga5Pdgfrb-cre embryos were often ﬁlled with
blood (Fig. 5D, S2) and consisted of both LYVE-1þ lymphatic ECs and
LYVE-1 ECs in both haemorrhaging (Fig. 5D) and non-haemo-
rrhaging mice (Fig. S6). The lack of LYVE-1þ/Prox1þ lymphatic endo-
thelial cells was particularly noticeable in the region directly adjacent
to the CV (Fig. 5D, S6), suggesting that the absence of a5 integrin in
these cells compromised the separation of JLS from CV in Itga5Pdgfrb-cre
mice, which as a result were susceptible to excessive amounts of blood
entering into the lymphatic circulation.
Previous studies have shown platelets are essential for separa-
tion of the JLS from the CV (Bertozzi et al., 2010). Mutant mice with
defects in podoplanin-induced platelet activation fail to separate
their lymphatic vessels from the blood circulation and, as a result,
develop blood-ﬁlled lymphatics (Bertozzi et al., 2010). Platelets
have been reported to express PDGFRβ in humans (Yang et al.,
1997), therefore, Itga5 might have been deleted from platelets
in our mutant mice and be the cause of the lymphatic defects
observed. However, deletion of Itga5 speciﬁcally within plate-
lets, using the Pf4-Cre mouse line (Tiedt et al., 2007) failed to
replicate the phenotype seen in Itga5Pdgfrb-cre mice. Itga5Pf4-cre mice
developed to term and formed organised lymphatic capillaries
within the skin (Fig. S7). Thus, the development of blood-ﬁlled
lymphatic vessels in Itga5Pdgfrb-cre mice is not due to platelet
defects.
Integrin-α5 is required for formation of the lymphovenous valves
In the human lymphatic malformation, fetal cystic hygroma,
failure to connect the LSs to the venous circulation results in large
swollen lymphatic vessels, oedema and, unless resolved, death due
to inability to drain interstitial ﬂuid back into the venous circula-
tion (Chervenak et al., 1983). To investigate whether the defects in
Itga5Pdgfrb-cre mice might also involve a failure to form the
lymphovenous valves, we analysed sequential coronal sections
through E15.5 control and mutant embryos. At E15.5, the lympho-
venous valves should have been fully formed for at least 48 h
(Fig. 4C, F–H) (Srinivasan and Oliver, 2011). Indeed, in control mice
(Fig. 6A–C) the ﬁrst valve of the left JLS is present just below the
vertebral artery, where the LS splits into two portions, and drains
into the IJV (arrow, Fig. 6B), while the second valve is positioned
more caudally, and drains into the junction of the IJV and SCV
(arrow, Fig. 6C). In oedematous Itga5Pdgfrb-cre mice how
ever, no obvious connections between the LSs and the venous
circulation were apparent, and despite careful examination of 30
oedematous embryos, no lymphovenous valves were detected
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Fig. 3. Itgα5Pdgfrb-cre mice display hyperplastic, blood-ﬁlled lymphatic vessels. (A-D) Confocal images showing the lymphatic capillaries (LYVE-1, green; note that LYVE-1 is
also expressed on macrophages) and erythrocytes (Ter119, red) in E15.5 control and Itgα5Pdgfrb-cre skin. In contrast to control mice (A and B), lymphatic vessels in Itgα5Pdgfrb-cre
mutants are hyperplastic, tortuous and ﬁlled with red blood cells (C and D). Inset shows 3D rendering of image in (D) conﬁrming presence of blood within the lymphatic
vessel. Blood vessels in Itgα5Pdgfrb-cre mice (strong PECAM stain, green) however remain unaffected by the deletion of integrin-α5 (E, F). Note lymphatic vessels (weak PECAM
stain) are also visible in both E and F. Scale bars: 50 μm.
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(Fig. 6D F). Instead, by E15.5, only Prox1þ lymphovenous valve
rudiments were found on the walls of both the jugular and
subclavian veins (Fig. 6E, F).
As a result, lymph ﬂuid and blood that has entered the lymph
sacs during the separation from the CV, is unable to drain into
the venous circulation, accumulates in the lymphatic network
(Fig. 6D, E), and leads to dilation of the lymph sac (Fig. 6D).
Interestingly, lymphovenous valves were found in Itga5Pdgfrb-cre
embryos that lacked any obvious signs of oedema (Fig. S8A).
Furthermore, in agreement with the predisposition of mutants to
develop a blood-ﬁlled JLS only on the left side of the embryo, we also
observed that in a large proportion of Itga5Pdgfrb-cre embryos analysed,
only the left lymphatic sac failed to connect to the venous endothe-
lium, and only in rare cases were both lymphovenous valves absent
(Fig. S8B). Lymphovenous valve defects have previously been
reported in mice lacking a single copy of the Prox1 transcription
factor and as a result they develop oedema and occasionally blood-
ﬁlled JLSs (Srinivasan and Oliver, 2011). In that study, the authors
proposed that the development of the lymphovenous valves is
dependent on expression of Prox1 in the population of venous ECs
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Fig. 4. Lymphatic expression of Pdgfrb-Cre. (A) Schematic representation of the position (modiﬁed from Srinivasan and Oliver (2011)) and morphology of the jugular
lymphatic sacs (JLS) and the lymphovenous valves in E13.5 mouse embryos. The head is orientated to the top and the heart towards the bottom of the ﬁgure. The JLS runs
from the neck posteriorly to the level of the thymus, where it is split into two portions by the vertebral artery (VA). The lymphovenous valves (dashed boxes) form at the end
of these two lymph sacs (LS) through the fusion of the posterior region of the LSs with the internal jugular (IJV) and subclavian (SCV) veins where they merge and drain into
the superior vena cava (SVC). Specialised Prox1þ Foxc2þ podoplaninþ venous endothelial cells (VECs) are found in these regions. The lymphovenous valve leaﬂets consist of
two layers of Prox1þ cells. The inner layer is composed of Prox1þ Foxc2- podoplanin lymphatic endothelial cells (LEC) from the LSs, while the outer layer is derived from
the Prox1þ Foxc2þ podoplanin- VECs. (B) Immunoﬂuorescence staining on a coronal section through the JLS of a Pdgfrbmtmg mouse at E13.5 (Pdgfrβþ cells will be GFPþ). Note
that the JLS appears to contain both GFPþ (yellow, arrows) and GFP- (red, arrowheads) lymphatic endothelial cells (B, enlarged in inset). (C) GFPþ cells are also present in a
population of cells in the IJV and SCV (arrows), adjacent to the JLS where the LS merge with venous circulation to form the lymphovenous valves. (D, E) Sequential transverse
sections stained with antibodies against the transcription factor Prox1 and (D) GFP and (E) PECAM showing Pdgfrb-Cre expression in the LS and in a specialised population of
venous endothelial cells within the IJV and SCV (arrows) in an E12.5 Pdgfrbmtmg embryo. Note the lack of Pdgfrb-Cre expression in Prox1-negative venous endothelium. (F)
Pdgfrbþ cells (arrows) in the outer layer of the lymphovenous valve. (G, H) Immunoﬂuorescence staining on a cryosection through the lymphovenous valve showing high
expression of (G) integrin-α5 and (H) integrin-α9 within the Prox1þ valve leaﬂets. Scale bars: 50 μm.
C.J. Turner et al. / Developmental Biology 392 (2014) 381–392 387
that contribute to formation of the valve leaﬂets. Loss of Prox1
expression did not seem to be the cause for the valve defects in
Itga5Pdgfrb-cre embryos however, since similar numbers of Prox1þ
vascular ECs were visible at regions adjacent to the lymphatic sacs, in
both control and Itga5Pdgfrb-cre mice (arrowhead, Fig. 6A, D).
Endothelial expression of both α5 and αv integrins are required for
proper lymphatic development
Since our results suggest that deletion of α5 in a subset of
venous endothelial cells, rather than mural cells (Fig. S5B) or
platelets (Fig. S7), is the cause of the lymphatic defects seen in
Itga5Pdgfrb-cre embryos, we re-examined embryos in which Itga5
had been deleted using Tie2-Cre, which is expressed in both the
lymphatic and blood vasculature. As previously reported by van
der Flier et al. (2010), on a C57BL/6 background none of the Itga5
ﬂox/KOTie2-cre embryos analysed developed oedema or blood-ﬁlled
lymphatics (Fig. S9A, B), and only relatively mild dilation of
lymphatics was observed (Fig. S9B). In contrast, on a 129S4
background, 40% of the Itga5 ﬂox/ﬂoxTie2-cre embryos developed
oedema (4/9 analysed), and hyperplastic blood-ﬁlled lymphatic
vessels (1/4 mutants) by E14.5 (Fig S9C, D), conﬁrming that the
lymphatic defects in Itga5Pdgfrb-cre embryos are indeed endothe-
lium-speciﬁc. The penetrance of this phenotype was enhanced
further by the addition of a single integrin-αv KO allele (Fig. S9E),
or by deleting both Itga5 and Itgav speciﬁcally within the
endothelium from E8.5 using the inducible VE-Cadherin-Creert2
mouse (6/6 mutants) (Fig. S9F). The phenotype of endothelium-
speciﬁc α5, and possibly Itga5Pdgfrb-cre embryos, appears therefore
to be dependent on a strain-dependent genetic modiﬁer and on
the ability of αv integrins to compensate for the loss of α5β1.
Discussion
We report here two unexpected ﬁndings about the role of α5β1
integrin in vascular development. First, ablation of α5 integrin
from mural cells fails to cause any notable defects in the
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development of the blood vasculature. Second, deletion of α5
integrin in Itga5Pdgfrb-cre mice produces lymphatic defects.
Integrin-α5 is dispensable for mural cell functions during vascular
development
Despite efﬁcient ablation of α5β1 integrin from mural cells
(Fig. S1B), blood vessels in Itga5Pdgfrb-cre embryos lack obvious mural
cell defects (Fig. 2). α5-deﬁcient pericytes covered capillaries and
extended long cellular extensions (Fig. 2H), while vSMCs formed
organised layers around the aorta (Fig. S1B) and aligned in concentric
rings around arteries within the skin of mutant mice (Fig. 2B). This
was particularly surprising since α5β1 is highly expressed on mural
cells (Fig. S1A) (Moiseeva, 2001). We have reported earlier that mice
lacking endothelial expression of α5β1 also fail to display the
angiogenic defects observed in global α5-KO mice (van der Flier
et al., 2010). Thus, α5β1 integrin seems to be largely dispensable in
each cell type for formation of the blood vasculature. It is possible
that α5β1 integrin in both cell types contributes to assembly of a
ﬁbronectin-rich ECM between them and that either cell type can
perform this function. Alternatively, other ﬁbronectin-binding integ-
rins could contribute overlapping or compensatory functions that
cover for the absence of α5β1 integrin. αv integrins can also
assemble ﬁbronectin but global knockouts of all αv integrins or
ablation of αvβ3 and αvβ5 also fail to produce general vascular
defects (Bader et al., 1998; Hodivala-Dilke et al., 1999; Huang et al.,
2000a; Reynolds et al., 2002), demonstrating that, if αv integrins are
involved, they are less essential than α5β1 integrin. We have shown
that mice lacking endothelial expression of both α5 and αv integrin
subunits, both of which are capable of ﬁbronectin assembly in vitro,
show no obvious defects in the deposition of ﬁbronectin within their
basement membranes in vivo (van der Flier et al., 2010).
Mural cell deletion of Itgb1, the common beta subunit of a dozen
different integrins, including α5, as well as other potential minor
ﬁbronectin receptors (α4, α8, α9) allows development until late in
gestation, although skin vessels do show dilations. Some pups are
born but, postnatally, aneurysms form and the mural cells show defe-
cts in their adherence to vessels and in the assembly of ﬁbronectin and
other ECM proteins around vessels within the skin (Abraham et al.,
2008). None of those other alpha subunits, when individually deleted
globally, has much if any effect on vascular development and, in the
absence of α5β1 on mural cells, αv integrins are presumably still
expressed by the mural cells. In light of these results, there are two
possible explanations for the absence of detectable blood vessel
defects in Itga5Pdgfrb-cre embryos. First, the role of α5 may be
adequately replaced (through overlapping functions or by compensa-
tion) by other integrins expressed on the mural cells, or by α5
expressed on ECs during angiogenesis. Mural cells express several
ﬁbronectin receptors (α5β1, αvβ3, αvβ5, αvβ6, α4β1) (Moiseeva,
2001), and defects in pericyte and vSMCs distribution have been
reported in α4-KO mice (Garmy-Susini et al., 2005; Grazioli et al.,
2006). To address these possibilities, tissue-speciﬁc mutants lacking
multiple ﬁbronectin integrins and mice lacking α5 in both endothelial
and mural cell compartments will need to be studied. Second, mural
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cell function and vessel stability may in fact, be more reliant on the
collagen and laminin receptors included among the β1 integrins.
vSMCs reportedly express high levels of α3β1 (a laminin receptor) and
α1β1 (a collagen receptor) in vivo; however to date, only the α7β1
integrin (another laminin receptor) has been shown to have a role in
mural cell function during development (Flintoff-Dye et al., 2005).
Selective deletion of α5β1 integrin causes lymphatic defects
Lymphatic malformations occur 1 in 1750 live births and 1 in 200
spontaneous abortions. The exact genes and cells involved in these
malformations remain unclear. Here we report that α5β1, the major
ﬁbronectin receptor, is essential for proper lymphatic development.
Reminiscent of the lymphatic malformation, fetal cystic hygroma
(Chervenak et al., 1983), Itga5Pdgfrb-cre embryos fail to form lympho-
venous valves on their left side (Fig. 6D–F). Consequently, α5
mutants fail to drain their left jugular lymph sacs into the venous
circulation, accumulate interstitial ﬂuid in their lymphatic circulation
and develop swollen hyperplastic lymphatic vessels and oedema
(Figs. 1B, 3C). Itga5Pdgfrb-cre mice that manage to connect their JLSs
before intrauterine death appear to resolve their oedema and survive
to birth (Fig. S2, S8). Nevertheless, even without obvious persistent
oedema, these mice still displayed enlarged lymphatic vessels and
ectopic smooth muscle cell coverage around their capillary lymphatic
vessels (Fig. 2D, E), just as observed in patients with lymphedema
distichiasis, and in mice lacking the transcription factor Foxc2
(Petrova et al., 2004). Interestingly, lymphatic hyperplasia and
abnormal recruitment of vSMCs to the lymphatic capillaries, without
blood vessel defects, are also seen in mice lacking the PDZ-binding
domain of ephrin-B2, which like FoxC2 mutants have defective
lymphatic valves and abnormal lymphatic circulation (Makinen
et al., 2005; Petrova et al., 2004). Intriguingly, deletion of ephrin-
B2 using the same Pdgfrb-Cre line used in this study, also leads to
ectopic vSMC cell coverage on the dermal lymphatic capillaries, in
addition to causing mural cell defects (Foo et al., 2006).
Since the majority of Itga5Pdgfrb-cre embryos developed oedema in
the absence of obvious haemorrhaging, and blood-ﬁlled lymph sacs
were observed before the formation of the lymphovenous valves at
E12.5 (Fig. 5D, S2), we believe that the appearance of a blood-ﬁlled
lymphatic network in α5 mutants requires both a delay in the
separation of the JLS from the CV (Fig. 5D) and defective lymphove-
nous valve formation (Fig. 6). Previous studies have shown that, even
in wild-type mice, blood can enter the lymphatic circulation as the
nascent lymph sacs bud from the CV (Francois et al., 2012; van der
Putte, 1975). Therefore, prolonging this process would result in
excess blood entering the lymphatic system. Indeed, numerous
reports have shown that failure or delay in separating the JLS from
the CV results in blood-ﬁlled lymphatic vasculature (Abtahian et al.,
2003; D'Amico et al., 2009; Uhrin et al., 2010). In wild-type mice,
blood that enters during development is, most likely, drained back
into the venous circulation via the lymphovenous valves. However,
since no such connection is made in the majority of Itga5Pdgfrb-cre
embryos by E15.5, this blood is prevented from leaving the lympha-
tics and leads to the blood-ﬁlled phenotype observed. Interestingly,
blood-ﬁlled lymphatics have also been reported to occur in Prox1
heterozygous mutants, which also lack lymphovenous valves
(Srinivasan and Oliver, 2011). In that study, the authors suggest that
blood could enter the lymphatic circulation through the formation of
abrupt fusions between the lymph sac and the IJV close to the valves
(Srinivasan and Oliver, 2011). However, since o10% of Prox1
heterozygous embryos develop blood-ﬁlled lymphatic vessels
(Srinivasan and Oliver, 2011) and an abrupt fusion between the LS
and the IJV was only seen in one Itga5Pdgfrb-cre embryo (data not
shown), it is unlikely that this connection is the primary site where
blood enters the lymphatic circulation in our mutant embryos.
Expression of PDGFRβ and integrin α5β1 during lymphatic
development
Our analysis of Pdgfrb-Cre expression during embryonic develop-
ment suggests that the lymphatic defects observed in Itga5Pdgfrb-cre
embryos are caused by loss of α5β1 in a specialised population of
Prox1þ Pdgfrbþ venous endothelial cells that contribute to the outer
layer of the lymphovenous valve leaﬂets (Fig. 4C–G). Elegant work
from Srinivasan and Oliver (2011) has shown that these cells also
express the transcription factor Foxc2, in contrast to the lymphatic
ECs that form the inner layer of the valve leaﬂets which are Prox1þ
but Foxc2 (Fig. 4A). Interestingly, Foxc2 is a direct transcriptional
activator of PDGFRβ expression and promotes mesenchymal transi-
tion (Hollier et al., 2013). This suggests that expression of PDGFRβ
within the outer layer of the valves and in the JLS is downstream of
Foxc2, and therefore of Prox1 (Harada et al., 2009), and may indicate
an important role for PDGF-B signalling in formation of both the JLS
and the lymphovenous valves. Consistent with this model, Pdgfb KO
mice, in addition to displaying severe blood vasculature defects, also
display dilated, tortuous, blood-ﬁlled lymphatic vessels, analogous to
those seen in Itga5Pdgfrb-cre embryos (Haiko, 2008). Furthermore, mice
lacking a single copy of Prox1 lose expression of Prox1 and Foxc2 in
the cells within the IJV and SCV that contribute to the outer layer of
the valve and fail to develop lymphovenous valves (Srinivasan and
Oliver, 2011).
Possible roles of integrin-α5 in lymphatic development
In this study, we have found that α5 is highly expressed in the
lymphovenous valves (Fig. 4G), and is required by the specialised
population of Prox1þ Pdgfrbþ-expressing cells for the proper forma-
tion of the JLS and the lymphovenous valves. The importance of α5
within these cells could be attributable to several factors. First, α5
may be mediating growth factor signalling. Integrin-α5 is required
for optimal activation of the lymphatic endothelial growth factor
receptor, VEGFR-3 (Zhang et al., 2005), and proliferation of lymphatic
ECs is blocked by small-molecule antagonists of α5β1 in vitro
(Dietrich et al., 2007). α5β1 has also been implicated in the activation
of PDGFRβ, in the absence of growth factor stimulation, and anti-α5
blocking antibodies signiﬁcantly reduce PDGFRβ phosphorylation
(Veevers-Lowe et al., 2011). Second, loss of α5 may reduce cell
migration or adhesion of cells to ﬁbronectin and ﬁbrillin, the main
component of the anchoring ﬁlaments securing lymphatic vessels to
the interstitial matrix. Finally, α5 may be required for deposition of
ﬁbronectin. Integrin-α5 plays a major role in assembly of ﬁbronectin
(Wierzbicka-Patynowski and Schwarzbauer, 2003) and loss of α5 in
either vascular or lymphatic ECs leads to a reduction in ﬁbronectin
ﬁbrillogenesis (Bazigou et al., 2009; van der Flier et al., 2010).
Interestingly, assembly of ﬁbronectin containing the extra type III
domain (EIIIA) has been shown to be essential for the elongation of
the intra-lymphatic valve leaﬂets (Bazigou et al., 2009). Mice lacking
endothelial integrin-α9, fail to organise EIIIAþ ﬁbronectin into
ﬁbrils and as a result develop ring-like valve structures that are
unable to prevent the backﬂow of lymph ﬂuid within the body
(Bazigou et al., 2009). It is conceivable therefore, that a similar
process regulates the development of lymphovenous valve leaﬂets.
Conclusions
Despite numerous in vitro and in vivo studies, the roles of α5β1 in
vascular development remain unclear. Both endothelial and mural
cells express α5β1 during development but it is not essential in either
cell type alone – maybe it functions similarly and, to some degree
redundantly, in both cell types, for example in correct assembly of
extracellular matrix. Furthermore, other integrins appear to play more
C.J. Turner et al. / Developmental Biology 392 (2014) 381–392390
minor, but perhaps overlapping, functions in vascular development.
Some such functions have been revealed in experiments where
multiple integrins have been ablated (van der Flier et al., 2010) and
additional experiments of that sort, although difﬁcult to accomplish,
may shed further light on the complex roles of integrins in develop-
ment of the cardiovascular system. It is also becoming clear that
integrins, in particular ﬁbronectin-binding integrins, have prominent
roles in controlling the development of the lymphatic system. Mice
lacking integrin-α9 develop abnormal lymphatic valves and chy-
lothorax (Bazigou et al., 2009; Huang et al., 2000b), while integrin-
α4 is required for tumor lymphangiogenesis (Garmy-Susini et al.,
2010). Our present study has shown that integrin α5β1 is essential in a
subset of Pdgfrbþ cells for the proper separation of the blood and
lymphatic vasculature and the development of the lymphovenous
valves. Thus, while the known roles served by integrins in vascular
and lymphatic development continue to increase, there undoubtedly
remain yet other contributions to be discovered.
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